Five ways analytics technologies are revolutionizing health care

Posted by Nitin Mittal and Michael Brooks on June 30, 2017

We have grown comfortable with the automation of daily functions such as booking flights, online shopping, and moving funds between bank accounts. But the newest generation of technology offers much more. By enhancing human thoughts and actions, cutting-edge analytics capabilities are forward looking and prescriptive, enabling a technological revolution that impacts many areas of the health care industry.

Continue reading “Five ways analytics technologies are revolutionizing health care”

Analytics in healthcare: Finding value in volumes of data

Posted by Chris DeBeer, Principal, Deloitte Consulting LLP on January 27, 2017.

As healthcare shifts its focus from volume to value, enterprise analytics is poised to play a critical role. There’s an increasing emphasis on creating long-term views of patient populations, which is made clear in the bundled payment regulations coming from the Centers for Medicare & Medicaid Services (CMS). Robust analytics are key to defining populations, understanding the care that’s provided, and determining variations across practitioners, physicians, and regions.

Continue reading “Analytics in healthcare: Finding value in volumes of data”

A smartphone-enabled journey toward a healthier future

Posted by Preeta Banerjee on January 06, 2017

Most of us love traveling. What about a journey inside the human body? Movies such as “Fantastic Voyage,” where shrinking to microscopic size allows humans to enter a patient’s body to save his life, may still be in the realm of science fiction, but to some extent, the vision has been realized via modern endoscopic techniques. Technology to monitor the body from inside and to deliver medicine to the exact spot of the disease or injury might change the way illnesses are prevented and cured in future.

Continue reading “A smartphone-enabled journey toward a healthier future”

Moving to a precision medicine model in pharma

Posted by Nitin Mittal on October 10, 2016

Pharmaceutical companies have operated the same way for decades. Conduct R&D, run clinical trials, endure the regulatory gauntlet, and swing for a home run. This blockbuster-driven business model has produced miracle drugs and flops, winners and losers. And now, it’s going away.

Instead of investing in drugs whose success hinges on risky bets with their inevitable boom or bust cycles, pharma companies are pivoting to a precision medicine-based model–developing drugs to impact a specific patient’s malady or condition.

Continue reading “Moving to a precision medicine model in pharma”